[ad_1] One of the most valuable private companies in the biotechnology sector has finally gone public. Moderna Therapeutics, a company developing messenger RNA-based treatments, achieved a $ 7 billion private valuation. On …
Read More »
[ad_1] Xconomy Boston – One of the biggest bets in the history of biotechnology is about to be tested on Wall Street. Moderna, the high-flying but secretive developer of messenger RNAs, filed …
Read More »
[ad_1] MOderna Therapeutics, a biotech company valued at more than $ 7 billion, is plotting to raise $ 500 million in what would be the sector's largest-ever initial public offering. The company, …
Read More »
[ad_1] Moderna Inc. has filed an initial public offering to sell for $ 500 million worth of shares, according to a statement Friday. Cambridge, Massachusetts, a biotech company, has named Morgan Stanley, …
Read More »